Location History:
- Victoria, AU (1998)
- Melbourne, AU (2001)
Company Filing History:
Years Active: 1998-2001
Title: R L Moritz: Innovator in Cancer Research
Introduction
R L Moritz is a prominent inventor based in Melbourne, Australia, known for his significant contributions to cancer research. He holds two patents that focus on isolated proteins and nucleic acids related to colon cancer. His work aims to enhance diagnostic and therapeutic methods for cancer treatment.
Latest Patents
Moritz's latest patents include innovations related to isolated nucleic acids that encode proteins binding to the A33 antibody. These inventions involve proteins and peptides found on the surface of colon cells and colon cancer cells. The proteins and peptides are designed to bind to tumor-associated antibodies, such as mAb 33. The monomeric protein has a molecular weight of approximately 43 kD, as determined by SDS gel electrophoresis under non-reducing conditions. Furthermore, these inventions encompass the use of nucleic acid molecules and proteins in both monomeric and multimeric forms, along with antibodies specific to these peptides for diagnostic, screening, and therapeutic applications.
Career Highlights
R L Moritz is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer biology. His work has been instrumental in developing innovative approaches to cancer treatment and diagnosis.
Collaborations
Some of Moritz's notable coworkers include Lloyd J Old and Sydney Welt, who have also made significant contributions to the field of cancer research.
Conclusion
R L Moritz is a key figure in the realm of cancer research, with patents that hold promise for improving cancer diagnostics and therapies. His innovative work continues to impact the scientific community and the fight against cancer.